Discover the detailed record of transactions filed by 叶兰, Director. Insider active across 1 company, notably 派林生物. In total, 46 disclosures have been recorded. History available since 2 January 2025. The latest transaction was disclosed on 25 April 2025 (Purchase). Regulator: SSE / SZSE (CSRC). All data is accessible without signup.
Declarations 46 total
● 董事 · Executives · 27 Nov 2025 · 福鞍股份 80,000 shares A股 SSE:173000009835496400 ● 董事 · Executives · 24 Nov 2025 · 福鞍股份 30,000 shares A股 SSE:173000009827576740 ● 董事 · Executives · 17 Nov 2025 · 福鞍股份 30,000 shares A股 SSE:173000009783837660 ● 高级管理人员 · Executives · 17 Nov 2025 · 福鞍股份 8,000 shares A股 SSE:173000009783837730 ● 董事 · Executives · 13 Nov 2025 · 福鞍股份 10,000 shares A股 SSE:173000009775577400 ● 董事 · Executives · 11 Nov 2025 · 福鞍股份 69,900 shares A股 SSE:173000009738442370 ● 董事 · Executives · 10 Nov 2025 · 福鞍股份 20,000 shares A股 SSE:173000009726371520 ● 董事 · Executives · 6 Nov 2025 · 福鞍股份 6,000 shares A股 SSE:173000009717809800 ● 高级管理人员 · Executives · 6 Nov 2025 · 福鞍股份 20,000 shares A股 SSE:173000009717809440 ● 高级管理人员 · Executives · 6 Nov 2025 · 福鞍股份 10,000 shares A股 SSE:173000009717809470 ● 董事 · Executives · 5 Nov 2025 · 福鞍股份 50,000 shares A股 SSE:173000009712471970 ● 高管 · Executives · 25 Apr 2025 · 派林生物 5,000 shares A股 SZSE:173000008868500400 Ideal exit: 20 Jan 2026 (T+270) ● 董秘 · Executives · 25 Apr 2025 · 派林生物 7,500 shares A股 SZSE:173000008868500580 Ideal exit: 20 Jan 2026 (T+270) ● 董事,高管 · Executives · 24 Feb 2025 · 派林生物 200 shares A股 SZSE:173000008717793300 Ideal exit: 21 Nov 2025 (T+270) ● 董事,高管 · Executives · 13 Feb 2025 · 派林生物 2,000 shares A股 SZSE:173000008552387420 Ideal exit: 10 Nov 2025 (T+270) ● 监事 · Executives · 14 Jan 2025 · 派林生物 1,500 shares A股 SZSE:173000008451201340 Ideal exit: 11 Oct 2025 (T+270) ● 监事 · Executives · 7 Jan 2025 · 派林生物 800 shares A股 SZSE:173000008409120800 Ideal exit: 4 Oct 2025 (T+270) ● 高管 · Executives · 6 Jan 2025 · 派林生物 10,000 shares A股 SZSE:173000008405393340 Ideal exit: 3 Oct 2025 (T+270) ● 董秘 · Executives · 6 Jan 2025 · 派林生物 2,000 shares A股 SZSE:173000008405393300 Ideal exit: 3 Oct 2025 (T+270) ● 高管 · Executives · 2 Jan 2025 · 派林生物 5,000 shares A股 SZSE:173000008396452540 Ideal exit: 29 Sept 2025 (T+270) ● 监事 · Executives · 2 Jan 2025 · 派林生物 2,000 shares A股 SZSE:173000008396452580 Ideal exit: 29 Sept 2025 (T+270) ● 高管 · Executives · 14 Nov 2024 · 尤夫股份 5,700 shares A股 SZSE:173000008264542800 Ideal exit: 11 Aug 2025 (T+270) ● 董事 · Executives · 30 Sept 2024 · 尤夫股份 4,000 shares A股 SZSE:173000008138114020 Ideal exit: 27 Jun 2025 (T+270) ● 董事 · Executives · 25 Jul 2024 · 尤夫股份 8,000 shares A股 SZSE:173000007882566600 Ideal exit: 21 Apr 2025 (T+270) ● 董事 · Executives · 26 Jun 2023 · 派林生物 3,500,000 shares A股 SZSE:173000006682573300 25 of 46 declarations
Load more (21 remaining) About 叶兰 Ye Lan is a director and executive at 派林生物, where she contributes to defining strategies and overseeing operations. With expertise in the biotechnology sector, she is involved in assessing the company's performance and implementing innovative solutions. Her commitment to regulatory compliance and ethics is essential to ensure the company's sustainability.